For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
0
views
Article has an altmetric score of 45
5
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cost-Related Prescription Drug Rationing by Adults With Obesity

      research-article
      Author(s): , MD, MPH 1 , , , BS 2 , , PhD, MPH 3 , , MD, MHS 1 , 4 , 5 , 6 , , PhD, MPH 7 , , MD, MHS 6 , 8
      Publication date (Electronic):
      Journal: JAMA Network Open
      Publisher: American Medical Association

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This cross-sectional study analyzes data from the National Health Interview Survey to examine the prevalence of cost-related prescription drug rationing by adults with obesity.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: found

          Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

          A Lincoff, Kirstine Brown-Frandsen, Helen Colhoun … (2023)
          Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular risk associated with overweight and obesity in the absence of diabetes is unknown.
          Article 0 comments Cited 396 times – based on 0 reviews     Review now
          Article has an altmetric score of 6265
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Financial burden, distress, and toxicity in cardiovascular disease.

            Samuel D Slavin, Rohan Khera, S Yousuf Zafar … (2021)
            Cardiovascular disease (CVD) is a major source of financial burden and distress, which has 3 main domains: (1) psychological distress; (2) cost-related care non-adherence or medical care deferral, and (3) tradeoffs with basic non-medical needs. We propose 4 ways to reduce financial distress in CVD: (1) policymakers can expand insurance coverage and curtail underinsurance; (2) health systems can limit expenditure on low-benefit, high-cost treatments while developing services for high-risk individuals; (3) physicians can engage in shared-decision-making for high-cost interventions, and (4) community-based initiatives can support patients with system navigation and financial coping. Avenues for research include (1) analysis of how healthcare policies affect financial burden; (2) comparative effectiveness studies examining high and low-cost strategies for CVD management; and (3) studying interventions to reduce financial burden, financial coaching, and community health worker integration.
            Article 0 comments Cited 23 times – based on 0 reviews     Review now
            Article has an altmetric score of 7
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              US Public’s Perspective on Prescription Drug Costs

              Ashley E. Kirzinger, Cailey Muñana, Rachel Fehr … (2019)
              Article 0 comments Cited 3 times – based on 0 reviews     Review now
              Article has an altmetric score of 148
                Bookmark
                All references

                Author and article information

                Journal
                Journal ID (nlm-ta): JAMA Netw Open
                Journal ID (iso-abbrev): JAMA Netw Open
                Title: JAMA Network Open
                Publisher: American Medical Association
                ISSN (Electronic): 2574-3805
                Publication date (Electronic): 5 November 2024
                Publication date Collection: November 2024
                Publication date PMC-release: 5 November 2024
                Volume: 7
                Issue: 11
                Electronic Location Identifier: e2433000
                Affiliations
                [1 ]National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
                [2 ]Yale School of Medicine, New Haven, Connecticut
                [3 ]Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut
                [4 ]Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
                [5 ]Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut
                [6 ]Center for Outcomes Research and Evaluation, Yale New Haven Health System, New Haven, Connecticut
                [7 ]Equity Research and Innovation Center, Yale School of Medicine, New Haven, Connecticut
                [8 ]Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
                Author notes
                Article Information
                Accepted for Publication: July 11, 2024.
                Published: November 5, 2024. doi:10.1001/jamanetworkopen.2024.33000
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Chen AS et al. JAMA Network Open.
                Corresponding Author: Alissa S. Chen, MD, MPH, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510 ( alissa.chen@ 123456yale.edu ).
                Author Contributions: Dr Chen had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Chen, Lipska.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Chen.
                Critical review of the manuscript for important intellectual content: All authors.
                Statistical analysis: Chen, Borden, Canavan.
                Administrative, technical, or material support: Oladele.
                Supervision: Lipska.
                Conflict of Interest Disclosures: Dr Ross reported receiving grants from the Food and Drug Administration, Johnson & Johnson, Medical Device Innovation Consortium, Agency for Healthcare Research and Quality, National Institutes of Health or National Heart, Lung, and Blood Institute, and Arnold Ventures outside the submitted work. Dr Ross was an expert witness at the request of Relator's attorneys, the Greene Law Firm, in a qui tam suit alleging violations of the False Claims Act and Anti-Kickback Statute against Biogen Inc, which was settled in September 2022. Dr Oladele reported receiving grants from the National Institutes of Health during the conduct of the study. Dr Lipska reported receiving personal fees from UpToDate to write and edit content and other fees from Centers for Medicare and Medicaid Services Support to develop and evaluate publicly reported quality measures outside the submitted work. No other disclosures were reported.
                Funding/Support: Dr Chen was funded by grant T32 AG019134 from the National Institute on Aging outside the submitted work. Dr Chen was funded as a Yale National Clinician Scholar.
                Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Data Sharing Statement: See Supplement 2.
                Article
                Publisher ID: zld240147
                DOI: 10.1001/jamanetworkopen.2024.33000
                PMC ID: 11539006
                PubMed ID: 39499520
                SO-VID: c3b4e733-5947-46e5-872d-bfb137a6d1c8
                Copyright © Copyright 2024 Chen AS et al. JAMA Network Open.
                License:

                This is an open access article distributed under the terms of the CC-BY License.

                History
                Date received : 5 March 2024
                Date accepted : 11 July 2024
                Categories
                Subject: Research
                Subject: Research Letter
                Subject: Online Only
                Subject: Diabetes and Endocrinology

                Data availability:

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Most referenced authors54

                See all reference authors